Global Drugs for Treatment of Multiple Myeloma Market Research Report to 2020

July 2016 | 121 pages | ID: G913BF73269EN
QYResearch

Abstracts

This report studies Drugs for Treatment of Multiple Myeloma in Global market, especially in USA, EU, China, Japan, Southeast Asia and India, focuses on top players in these countries, with production, price, revenue and market share in Global market, like
Janssen
Celgene
Bristol-Myers Squibb
Grunenthal GmbH
Takeda
Novartis
Changzhou Pharmaceutical Factory
Cinkate Corporation
Aspen Pharmacare
Harbin Medical Pharmaceutical
Market Segment by Regions, this report splits Global into several key countries, with production, consumption, revenue, market share and growth rate of Drugs for Treatment of Multiple Myeloma in these countries, from 2011 to 2020 (forecast), like
USA
China
EU
Japan
Southeast Asia
India
Rest of Global
Split by product types, with production, revenue, price, market share and growth rate of each type, can be divided into
Bortezomib
Pomalyst
Empliciti
Lenalidomide capsules
Ixazomib
Farydak
Thalidomide
Melphalan
Arsenious Acid
Split by applications, this report focuses on consumption, market share and growth rate of Drugs for Treatment of Multiple Myeloma in each application, can be divided into
Multiple Myeloma

Contents

Global Drugs for Treatment of Multiple Myeloma Market Research Report to 2020

1 DRUGS FOR TREATMENT OF MULTIPLE MYELOMA OVERVIEW

1.1 Product Overview and Scope of Drugs for Treatment of Multiple Myeloma
1.2 Drugs for Treatment of Multiple Myeloma Segment by Type
  1.2.1 Bortezomib and Production Growth Rate 2011-2020
  1.2.2 Pomalyst and Production Growth Rate 2011-2020
  1.2.3 Empliciti and Production Growth Rate 2011-2020
  1.2.4 Lenalidomide capsules and Production Growth Rate 2011-2020
  1.2.5 Ixazomib and Production Growth Rate 2011-2020
  1.2.6 Farydak and Production Growth Rate 2011-2020
  1.2.7 Thalidomide and Production Growth Rate 2011-2020
  1.2.8 Melphalan and Production Growth Rate 2011-2020
  1.2.9 Arsenious Acid and Production Growth Rate 2011-2020
1.3 Drugs for Treatment of Multiple Myeloma Segment by Applications
  1.3.1 Drugs for Treatment of Multiple Myeloma Consumption Market Share by Applications in 2015 and 2016
  1.3.2 Multiple Myeloma and Key Clients (Buyers) List
1.4 Drugs for Treatment of Multiple Myeloma Market by Regions
  1.4.1 USA Status and Prospect 2011-2020
  1.4.2 China Status and Prospect 2011-2020
  1.4.3 EU Status and Prospect 2011-2020
  1.4.4 Japan Status and Prospect 2011-2020
  1.4.5 Southeast Asia Status and Prospect 2011-2020
  1.4.6 India Status and Prospect 2011-2020
1.5 Global Market Size (Value and Volume) of Drugs for Treatment of Multiple Myeloma 2011-2020
  1.5.1 Global Drugs for Treatment of Multiple Myeloma Capacity, Production and Growth Rate 2011-2020
  1.5.2 Global Drugs for Treatment of Multiple Myeloma Revenue and Growth Rate 2011-2020

2 GLOBAL DRUGS FOR TREATMENT OF MULTIPLE MYELOMA MARKET COMPETITION BY MANUFACTURERS

2.1 Global Drugs for Treatment of Multiple Myeloma Production and Share by Manufacturers (2015 and 2016)
2.2 Global Drugs for Treatment of Multiple Myeloma Revenue and Share by Manufacturers (2015 and 2016)
2.3 Global Drugs for Treatment of Multiple Myeloma Average Price by Manufacturers (2015 and 2016)
2.4 Manufacturers Drugs for Treatment of Multiple Myeloma Manufacturing Base Distribution and Product Type

3 GLOBAL DRUGS FOR TREATMENT OF MULTIPLE MYELOMA MARKET ANALYSIS BY TYPE AND APPLICATIONS

3.1 Global Drugs for Treatment of Multiple Myeloma Production, Market Share and Growth Rate by Type (2011-2020)
3.2 Global Drugs for Treatment of Multiple Myeloma Revenue, Market Share and Growth Rate by Type (2011-2020)
3.3 Drugs for Treatment of Multiple Myeloma Average Price by Type in 2015
3.4 Global Drugs for Treatment of Multiple Myeloma Consumption, Market Share and Growth Rate by Applications 2011-2020

4 GLOBAL DRUGS FOR TREATMENT OF MULTIPLE MYELOMA MANUFACTURERS ANALYSIS

4.1 Janssen
  4.1.1 Company Basic Information, Manufacturing Base and Competitors
  4.1.2 Product Type and Technology of Janssen
    4.1.2.1 Tylenol Price and Specification
    4.1.2.2 Pseudo Asami Safin drops Price and Specification
    4.1.2.3 Levocabastine hydrochloride nasal spray Price and Specification
  4.1.3 Drugs for Treatment of Multiple Myeloma Capacity, Production, Revenue, Price of Janssen 2015 to 2016
4.2 Celgene
  4.2.1 Company Basic Information, Manufacturing Base and Competitors
  4.2.2 Product Type and Technology of Celgene
    4.2.2.1 Thalidomide Price and Specification
    4.2.2.2 ISODAX? Price and Specification
    4.2.2.3 REVLIMID? Price and Specification
  4.2.3 Drugs for Treatment of Multiple Myeloma Capacity, Production, Revenue, Price of Celgene 2015 to 2016
4.3 Bristol-Myers Squibb
  4.3.1 Company Basic Information, Manufacturing Base and Competitors
  4.3.2 Product Type and Technology of Bristol-Myers Squibb
    4.3.2.1 Fosinopril sodium tablets Price and Specification
    4.3.2.2 Metformin hydrochloride tablets Price and Specification
    4.3.2.3 Dara oseltamivir hydrochloride tablets Price and Specification
  4.3.3 Drugs for Treatment of Multiple Myeloma Capacity, Production, Revenue, Price of Bristol-Myers Squibb 2015 to 2016
4.4 Grunenthal GmbH
  4.4.1 Company Basic Information, Manufacturing Base and Competitors
  4.4.2 Product Type and Technology of Grunenthal GmbH
    4.4.2.1 Bezafibrate sustained-release tablets Price and Specification
    4.4.2.2 Tramadol capsules release tablets Price and Specification
    4.4.2.3 Sadow Lee Price and Specification
  4.4.3 Drugs for Treatment of Multiple Myeloma Capacity, Production, Revenue, Price of Grunenthal GmbH 2015 to 2016
4.5 Takeda
  4.5.1 Company Basic Information, Manufacturing Base and Competitors
  4.5.2 Product Type and Technology of Takeda
    4.5.2.1 Lansoprazole Price and Specification
    4.5.2.2 Leuprolide Price and Specification
    4.5.2.3 Voglibose Price and Specification
  4.5.3 Drugs for Treatment of Multiple Myeloma Capacity, Production, Revenue, Price of Takeda 2015 to 2016
4.6 Novartis
  4.6.1 Company Basic Information, Manufacturing Base and Competitors
  4.6.2 Drugs for Treatment of Multiple Myeloma Capacity, Production, Revenue, Price of Novartis 2015 to 2016
4.7 Changzhou Pharmaceutical Factory
  4.7.1 Company Basic Information, Manufacturing Base and Competitors
  4.7.2 Drugs for Treatment of Multiple Myeloma Capacity, Production, Revenue, Price of Changzhou Pharmaceutical Factory 2015 to 2016
4.8 Cinkate Corporation
  4.8.1 Company Basic Information, Manufacturing Base and Competitors
  4.8.2 Drugs for Treatment of Multiple Myeloma Capacity, Production, Revenue, Price of Cinkate Corporation 2015 to 2016
4.9 Aspen Pharmacare
  4.9.1 Company Basic Information, Manufacturing Base and Competitors
  4.9.2 Drugs for Treatment of Multiple Myeloma Capacity, Production, Revenue, Price of Aspen Pharmacare 2015 to 2016
4.10 Harbin Medical Pharmaceutical
  4.10.1 Company Basic Information, Manufacturing Base and Competitors
  4.10.2 Drugs for Treatment of Multiple Myeloma Capacity, Production, Revenue, Price of Harbin Medical Pharmaceutical 2015 to 2016

5 GLOBAL DRUGS FOR TREATMENT OF MULTIPLE MYELOMA MARKET ANALYSIS BY REGIONS 2011-2020

5.1 Global Drugs for Treatment of Multiple Myeloma Production by Regions 2011-2020
5.2 Global Drugs for Treatment of Multiple Myeloma Revenue by Regions 2011-2020
5.3 Global Drugs for Treatment of Multiple Myeloma Consumption by Regions 2011-2020
5.4 USA Drugs for Treatment of Multiple Myeloma Production, Consumption and Growth Rate 2011-2020
5.5 China Drugs for Treatment of Multiple Myeloma Production, Consumption and Growth Rate 2011-2020
5.6 EU Drugs for Treatment of Multiple Myeloma Production, Consumption and Growth Rate 2011-2020
5.7 Japan Drugs for Treatment of Multiple Myeloma Production, Consumption and Growth Rate 2011-2020
5.8 Southeast Asia Drugs for Treatment of Multiple Myeloma Production, Consumption and Growth Rate 2011-2020
5.9 India Drugs for Treatment of Multiple Myeloma Production, Consumption and Growth Rate 2011-2020

6 DRUGS FOR TREATMENT OF MULTIPLE MYELOMA TECHNOLOGY AND DEVELOPMENT TREND

6.1 Drugs for Treatment of Multiple Myeloma Technology Analysis
6.2 Drugs for Treatment of Multiple Myeloma Technology Development Trend

7 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Drugs for Treatment of Multiple Myeloma
Figure Picture of Bortezomib
Figure Bortezomib Production Growth Rate 2011-2020
Figure Picture of Pomalyst
Figure Pomalyst Production Growth Rate 2011-2020
Figure Picture of Empliciti
Figure Empliciti Production Growth Rate 2011-2020
Figure Picture of Lenalidomide capsules
Figure Lenalidomide capsules Production Growth Rate 2011-2020
Figure Picture of Ixazomib
Figure Ixazomib Production Growth Rate 2011-2020
Figure Picture of Farydak
Figure Farydak Production Growth Rate 2011-2020
Figure Picture of Thalidomide
Figure Thalidomide Production Growth Rate 2011-2020
Figure Picture of Melphalan
Figure Melphalan Production Growth Rate 2011-2020
Figure Picture of Arsenious Acid
Figure Arsenious Acid Production Growth Rate 2011-2020
Table Drugs for Treatment of Multiple Myeloma Consumption Market Share by Applications in 2015 and 2016
Table Drugs for Treatment of Multiple Myeloma Key Clients (Buyers) List in Multiple Myeloma
Figure USA Drugs for Treatment of Multiple Myeloma Production and Growth Rate 2011-2020
Figure USA Drugs for Treatment of Multiple Myeloma Consumption and Growth Rate 2011-2020
Figure China Drugs for Treatment of Multiple Myeloma Production and Growth Rate 2011-2020
Figure China Drugs for Treatment of Multiple Myeloma Consumption and Growth Rate 2011-2020
Figure EU Drugs for Treatment of Multiple Myeloma Production and Growth Rate 2011-2020
Figure EU Drugs for Treatment of Multiple Myeloma Consumption and Growth Rate 2011-2020
Figure Japan Drugs for Treatment of Multiple Myeloma Production and Growth Rate 2011-2020
Figure Japan Drugs for Treatment of Multiple Myeloma Consumption and Growth Rate 2011-2020
Figure Southeast Asia Drugs for Treatment of Multiple Myeloma Production and Growth Rate 2011-2020
Figure Southeast Asia Drugs for Treatment of Multiple Myeloma Consumption and Growth Rate 2011-2020
Figure India Drugs for Treatment of Multiple Myeloma Production and Growth Rate 2011-2020
Figure India Drugs for Treatment of Multiple Myeloma Consumption and Growth Rate 2011-2020
Figure Global Drugs for Treatment of Multiple Myeloma Capacity, Production and Growth Rate 2011-2020
Figure Global Drugs for Treatment of Multiple Myeloma Revenue and Growth Rate 2011-2020
Table Global Drugs for Treatment of Multiple Myeloma Production of Key Manufacturers (2015 and 2016)
Table Global Drugs for Treatment of Multiple Myeloma Production Share by Manufacturers (2015 and 2016)
Table Global Drugs for Treatment of Multiple Myeloma Revenue by Manufacturers (2015 and 2016)
Table Global Drugs for Treatment of Multiple Myeloma Revenue Share by Manufacturers (2015 and 2016)
Table Global Market Drugs for Treatment of Multiple Myeloma Average Price of Key Manufacturers (2015 and 2016)
Table Manufacturers Drugs for Treatment of Multiple Myeloma Manufacturing Base Distribution and Product Type
Table Global Drugs for Treatment of Multiple Myeloma Production by Type (2011-2020)
Table Global Drugs for Treatment of Multiple Myeloma Production Share by Type (2011-2020)
Table Global Drugs for Treatment of Multiple Myeloma Production Growth Rate by Type (2011-2020)
Table Global Drugs for Treatment of Multiple Myeloma Revenue by Type (2011-2020)
Table Global Drugs for Treatment of Multiple Myeloma Revenue Share by Type (2011-2020)
Table Global Drugs for Treatment of Multiple Myeloma Revenue Growth Rate by Type (2011-2020)
Table Drugs for Treatment of Multiple Myeloma Average Price by Type in 2015
Table Global Drugs for Treatment of Multiple Myeloma Consumption by Application 2011-2020
Table Global Drugs for Treatment of Multiple Myeloma Consumption Market Share by Application 2011-2020
Table Global Drugs for Treatment of Multiple Myeloma Consumption Growth Rate by Application 2011-2020
Table Janssen Basic Information List
Table Drugs for Treatment of Multiple Myeloma Capacity, Production, Revenue, Price of Janssen 2015 to 2016
Table Celgene Basic Information List
Table Drugs for Treatment of Multiple Myeloma Capacity, Production, Revenue, Price of Celgene 2015 to 2016
Table Bristol-Myers Squibb Basic Information List
Table Drugs for Treatment of Multiple Myeloma Capacity, Production, Revenue, Price of Bristol-Myers Squibb 2015 to 2016
Table Grunenthal GmbH Basic Information List
Table Drugs for Treatment of Multiple Myeloma Capacity, Production, Revenue, Price of Grunenthal GmbH 2015 to 2016
Table Takeda Basic Information List
Table Drugs for Treatment of Multiple Myeloma Capacity, Production, Revenue, Price of Takeda 2015 to 2016
Table Novartis Basic Information List
Table Drugs for Treatment of Multiple Myeloma Capacity, Production, Revenue, Price of Novartis 2015 to 2016
Table Changzhou Pharmaceutical Factory Basic Information List
Table Drugs for Treatment of Multiple Myeloma Capacity, Production, Revenue, Price of Changzhou Pharmaceutical Factory 2015 to 2016
Table Cinkate Corporation Basic Information List
Table Drugs for Treatment of Multiple Myeloma Capacity, Production, Revenue, Price of Cinkate Corporation 2015 to 2016
Table Aspen Pharmacare Basic Information List
Table Drugs for Treatment of Multiple Myeloma Capacity, Production, Revenue, Price of Aspen Pharmacare 2015 to 2016
Table Harbin Medical Pharmaceutical Basic Information List
Table Drugs for Treatment of Multiple Myeloma Capacity, Production, Revenue, Price of Harbin Medical Pharmaceutical 2015 to 2016
Table Global Drugs for Treatment of Multiple Myeloma Production by Regions 2011-2020
Table Global Drugs for Treatment of Multiple Myeloma Production Market Share by Regions 2011-2020
Figure Global Drugs for Treatment of Multiple Myeloma Production Market Share by Regions 2015
Table Global Drugs for Treatment of Multiple Myeloma Revenue by Regions 2011-2020
Table Global Drugs for Treatment of Multiple Myeloma Revenue Market Share by Regions 2011-2020
Figure Global Drugs for Treatment of Multiple Myeloma Revenue Market Share by Regions 2015
Table Global Drugs for Treatment of Multiple Myeloma Consumption by Regions 2011-2020
Table Global Drugs for Treatment of Multiple Myeloma Consumption Market Share by Regions 2011-2020
Figure Global Drugs for Treatment of Multiple Myeloma Consumption Market Share by Regions 2015
Figure USA Drugs for Treatment of Multiple Myeloma Production and Growth Rate 2011-2020
Figure USA Drugs for Treatment of Multiple Myeloma Consumption and Growth Rate 2011-2020
Figure China Drugs for Treatment of Multiple Myeloma Production and Growth Rate 2011-2020
Figure China Drugs for Treatment of Multiple Myeloma Consumption and Growth Rate 2011-2020
Figure EU Drugs for Treatment of Multiple Myeloma Production and Growth Rate 2011-2020
Figure EU Drugs for Treatment of Multiple Myeloma Consumption and Growth Rate 2011-2020
Figure Japan Drugs for Treatment of Multiple Myeloma Production and Growth Rate 2011-2020
Figure Japan Drugs for Treatment of Multiple Myeloma Consumption and Growth Rate 2011-2020
Figure Southeast Asia Drugs for Treatment of Multiple Myeloma Production and Growth Rate 2011-2020
Figure Southeast Asia Drugs for Treatment of Multiple Myeloma Consumption and Growth Rate 2011-2020
Figure India Drugs for Treatment of Multiple Myeloma Production and Growth Rate 2011-2020
Figure India Drugs for Treatment of Multiple Myeloma Consumption and Growth Rate 2011-2020